Log in

ALBPS Biophytis SA EURONEXT · France

Biophytis SA (ALBPS) news

Latest Biophytis SA news

We have not published a story on Biophytis SA yet. When there is news, it will appear here.

Questions about Biophytis SA

What is the ticker symbol of Biophytis SA?

Biophytis SA trades under the ticker ALBPS on EURONEXT.

Where is Biophytis SA listed?

Biophytis SA is listed on EURONEXT. Our directory also records these other listings: LSE:0D1W.

Which country or territory is Biophytis SA listed under?

Our directory records Biophytis SA under France.

What does Biophytis SA do?

Our directory classifies Biophytis SA as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Biophytis SA?

The ISIN recorded for Biophytis SA is FR001400OLP5.

Does aibio.space cover Biophytis SA?

aibio.space lists Biophytis SA among 2,820 public biotech companies and publishes its news here as stories appear.

What is the latest Biophytis SA (ALBPS) stock news?

Our latest story on Biophytis SA, dated May 27, 2026: "Biophytis changes Hexagon bond facility to make it revolving". Biophytis amended its straight bond financing with Hexagon Capital Fund a second time, making the facility revolving and reducing its cost. Source.

Does Biophytis SA have debt, a term loan or convertible notes?

Our latest debt story, dated May 27, 2026: "Biophytis changes Hexagon bond facility to make it revolving". Biophytis amended its straight bond financing with Hexagon Capital Fund a second time, making the facility revolving and reducing its cost. Source.

Which companies are similar to Biophytis SA?

Companies in our directory listed in the same country and business area as Biophytis SA: Abivax SA, Boiron SA, AB Science SA, ABIONYX Pharma SA, Aelis Farma SA, Gensight Biologics SA.

How can I follow Biophytis SA (ALBPS) news?

Press Follow on this page to add Biophytis SA to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming Biophytis SA so far, in Debt Financing.

Investor discussion: Biophytis SA

Members talk about Biophytis SA (ALBPS). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open EURONEXT:ALBPS on TradingView.

Listing details

Biophytis SA is a public biotech or pharmaceutical company listed on EURONEXT under the ticker ALBPS, recorded under France. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Biophytis SA
Ticker
ALBPS
Listing
EURONEXT
Country or territory
France
Business scope
Biopharma / pharmaceutical profile checked
ISIN
FR001400OLP5
Other listed symbols
LSE:0D1W
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.